Tech Company Financing Transactions

Accera Funding Round

Accera closed a $17.6 million financing round on 3/27/2018. Investors included private investors.

Transaction Overview

Company Name
Announced On
3/27/2018
Transaction Type
Venture Equity
Amount
$17,639,537
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3005 Center Green Dr. 205
Boulder, CO 80301
USA
Email Address
Overview
Accera is a clinical stage biotechnology company developing therapies for central nervous system disorders including Alzheimer's disease.
Profile
Accera LinkedIn Company Profile
Social Media
Accera Company Twitter Account
Company News
Accera News
Facebook
Accera on Facebook
YouTube
Accera on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charles Stacey
  Charles Stacey LinkedIn Profile  Charles Stacey Twitter Account  Charles Stacey News  Charles Stacey on Facebook
Chief Financial Officer
Evan Ballantyne
  Evan Ballantyne LinkedIn Profile  Evan Ballantyne Twitter Account  Evan Ballantyne News  Evan Ballantyne on Facebook
Chief Medical Officer
Judy Walker
  Judy Walker LinkedIn Profile  Judy Walker Twitter Account  Judy Walker News  Judy Walker on Facebook
VP - Bus. Development
Ernest Wong
  Ernest Wong LinkedIn Profile  Ernest Wong Twitter Account  Ernest Wong News  Ernest Wong on Facebook
VP - Finance
Jerris Knaisch
  Jerris Knaisch LinkedIn Profile  Jerris Knaisch Twitter Account  Jerris Knaisch News  Jerris Knaisch on Facebook
VP - R & D
Samuel Henderson
  Samuel Henderson LinkedIn Profile  Samuel Henderson Twitter Account  Samuel Henderson News  Samuel Henderson on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/27/2018: Embotics venture capital transaction
Next: 3/27/2018: Cardinal Analytx Solutions venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary